• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚乙二醇化纳米颗粒与血液免疫系统的相互作用。

The interplay between PEGylated nanoparticles and blood immune system.

机构信息

Department of Pharmaceutics, School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China.

School of Functional Food and Wine, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, Liaoning, PR China.

出版信息

Adv Drug Deliv Rev. 2023 Sep;200:115044. doi: 10.1016/j.addr.2023.115044. Epub 2023 Aug 2.

DOI:10.1016/j.addr.2023.115044
PMID:37541623
Abstract

During the last two decades, an increasing number of reports have pointed out that the immunogenicity of polyethylene glycol (PEG) may trigger accelerated blood clearance (ABC) and hypersensitivity reaction (HSR) to PEGylated nanoparticles, which could make PEG modification counterproductive. These phenomena would be detrimental to the efficacy of the load and even life-threatening to patients. Consequently, further elucidation of the interplay between PEGylated nanoparticles and the blood immune system will be beneficial to developing and applying related formulations. Many groups have worked to unveil the relevance of structural factors, dosing schedule, and other factors to the ABC phenomenon and hypersensitivity reaction. Interestingly, the results of some reports seem to be difficult to interpret or contradict with other reports. In this review, we summarize the physiological mechanisms of PEG-specific immune response. Moreover, we speculate on the potential relationship between the induction phase and the effectuation phase to explain the divergent results in published reports. In addition, the role of nanoparticle-associated factors is discussed based on the classification of the action phase. This review may help researchers to develop PEGylated nanoparticles to avoid unfavorable immune responses based on the underlying mechanism.

摘要

在过去的二十年中,越来越多的报告指出,聚乙二醇(PEG)的免疫原性可能引发对聚乙二醇化纳米颗粒的加速血液清除(ABC)和过敏反应(HSR),这可能使 PEG 修饰适得其反。这些现象将对负载的疗效产生不利影响,甚至对患者造成生命威胁。因此,进一步阐明聚乙二醇化纳米颗粒与血液免疫系统之间的相互作用将有助于开发和应用相关制剂。许多研究小组致力于揭示结构因素、给药方案和其他因素与 ABC 现象和过敏反应的相关性。有趣的是,一些报告的结果似乎难以解释或与其他报告相矛盾。在这篇综述中,我们总结了 PEG 特异性免疫反应的生理机制。此外,我们推测诱导阶段和实现阶段之间的潜在关系,以解释已发表报告中的分歧结果。此外,还根据作用阶段的分类讨论了纳米颗粒相关因素的作用。这篇综述可能有助于研究人员根据潜在机制开发避免不利免疫反应的聚乙二醇化纳米颗粒。

相似文献

1
The interplay between PEGylated nanoparticles and blood immune system.聚乙二醇化纳米颗粒与血液免疫系统的相互作用。
Adv Drug Deliv Rev. 2023 Sep;200:115044. doi: 10.1016/j.addr.2023.115044. Epub 2023 Aug 2.
2
The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage.加速血液清除(ABC)现象:临床挑战及应对方法。
J Control Release. 2013 Nov 28;172(1):38-47. doi: 10.1016/j.jconrel.2013.07.026. Epub 2013 Aug 7.
3
A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes.聚乙二醇化脂质体的羟基 PEG 化版本及其对抗聚乙二醇 IgM 诱导和聚乙二醇化脂质体加速清除的影响。
Eur J Pharm Biopharm. 2018 Jun;127:142-149. doi: 10.1016/j.ejpb.2018.02.019. Epub 2018 Feb 17.
4
The Contribution of PEG Molecular Weights in PEGylated Emulsions to the Various Phases in the Accelerated Blood Clearance (ABC) Phenomenon in Rats.聚乙二醇分子量在聚乙二醇化乳剂中对大鼠加速血液清除(ABC)现象各阶段的贡献。
AAPS PharmSciTech. 2020 Nov 2;21(8):300. doi: 10.1208/s12249-020-01838-2.
5
A higher dose of PEGylated gold nanoparticles reduces the accelerated blood clearance phenomenon effect and induces spleen B lymphocytes in albino mice.高剂量的聚乙二醇化金纳米粒子可降低加速血液清除现象的效果,并诱导白化小鼠脾脏 B 淋巴细胞。
Histochem Cell Biol. 2022 Jun;157(6):641-656. doi: 10.1007/s00418-022-02086-0. Epub 2022 Feb 14.
6
Relationship between the concentration of anti-polyethylene glycol (PEG) immunoglobulin M (IgM) and the intensity of the accelerated blood clearance (ABC) phenomenon against PEGylated liposomes in mice.小鼠体内抗聚乙二醇(PEG)免疫球蛋白M(IgM)浓度与针对聚乙二醇化脂质体的加速血液清除(ABC)现象强度之间的关系。
Biol Pharm Bull. 2015;38(3):417-24. doi: 10.1248/bpb.b14-00653.
7
Anti-PEG IgM and complement system are required for the association of second doses of PEGylated liposomes with splenic marginal zone B cells.抗聚乙二醇IgM和补体系统是第二剂聚乙二醇化脂质体与脾脏边缘区B细胞结合所必需的。
Immunobiology. 2015 Oct;220(10):1151-60. doi: 10.1016/j.imbio.2015.06.005. Epub 2015 Jun 6.
8
Accelerated blood clearance phenomenon upon cross-administration of PEGylated nanocarriers in beagle dogs.在比格犬中交叉给予聚乙二醇化纳米载体后出现的加速血液清除现象。
Int J Nanomedicine. 2015 May 14;10:3533-45. doi: 10.2147/IJN.S82481. eCollection 2015.
9
Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products.聚乙二醇(PEG):性质、免疫原性及在 PEG 化产品过敏反应中的作用。
J Control Release. 2022 Nov;351:215-230. doi: 10.1016/j.jconrel.2022.09.031. Epub 2022 Sep 22.
10
Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles.聚乙二醇化固体脂质纳米粒重复注射可诱导小鼠和比格犬的加速血液清除。
Int J Nanomedicine. 2012;7:2891-900. doi: 10.2147/IJN.S30943. Epub 2012 Jun 12.

引用本文的文献

1
Targeting Wnt-driven metabolic adaptations in cancer: integrating glycolysis, glutaminolysis, IDO1-mediated immune evasion, and therapeutic delivery strategies.靶向癌症中Wnt驱动的代谢适应性:整合糖酵解、谷氨酰胺分解、吲哚胺2,3-双加氧酶1介导的免疫逃逸及治疗递送策略
Front Cell Dev Biol. 2025 Aug 22;13:1622218. doi: 10.3389/fcell.2025.1622218. eCollection 2025.
2
Engineered iron oxide nanoplatforms: reprogramming immunosuppressive niches for precision cancer theranostics.工程化氧化铁纳米平台:重新编程免疫抑制微环境以实现精准癌症诊疗
Mol Cancer. 2025 Sep 1;24(1):225. doi: 10.1186/s12943-025-02443-2.
3
Revolutionizing healthcare: the transformative potential of nanotechnology in medicine.
变革医疗保健:纳米技术在医学中的变革潜力。
Front Drug Deliv. 2025 May 30;5:1556426. doi: 10.3389/fddev.2025.1556426. eCollection 2025.
4
PEGylation strategies for enhanced nanoparticle delivery to tumor associated immune cells.用于增强纳米颗粒向肿瘤相关免疫细胞递送的聚乙二醇化策略。
bioRxiv. 2025 Jul 27:2025.07.23.666401. doi: 10.1101/2025.07.23.666401.
5
Synergistic Cancer Therapies Enhanced by Nanoparticles: Advancing Nanomedicine Through Multimodal Strategies.纳米颗粒增强的协同癌症疗法:通过多模态策略推进纳米医学
Pharmaceutics. 2025 May 22;17(6):682. doi: 10.3390/pharmaceutics17060682.
6
Advancing the potential of nanoparticles for cancer detection and precision therapeutics.提升纳米颗粒在癌症检测和精准治疗方面的潜力。
Med Oncol. 2025 Jun 4;42(7):239. doi: 10.1007/s12032-025-02782-6.
7
Applications of Matrix Metalloproteinase-9-Related Nanomedicines in Tumors and Vascular Diseases.基质金属蛋白酶-9相关纳米药物在肿瘤和血管疾病中的应用
Pharmaceutics. 2025 Apr 7;17(4):479. doi: 10.3390/pharmaceutics17040479.
8
Nanoparticle Targeting Strategies for Lipid and Polymer-Based Gene Delivery to Immune Cells In Vivo.用于基于脂质和聚合物的基因体内递送至免疫细胞的纳米颗粒靶向策略
Small Sci. 2024 Jul 30;4(9):2400248. doi: 10.1002/smsc.202400248. eCollection 2024 Sep.
9
How Advanced Is Nanomedicine for Atherosclerosis?纳米医学在动脉粥样硬化治疗方面有多先进?
Int J Nanomedicine. 2025 Mar 17;20:3445-3470. doi: 10.2147/IJN.S508757. eCollection 2025.
10
Neutrophils-mediated accelerated blood clearance phenomenon in beagles and rats based on the cross-injection of non-PEGylated and PEGylated nanoemulsions.基于非聚乙二醇化和聚乙二醇化纳米乳剂交叉注射的比格犬和大鼠中性粒细胞介导的加速血液清除现象。
Int J Pharm X. 2025 Feb 19;9:100318. doi: 10.1016/j.ijpx.2025.100318. eCollection 2025 Jun.